Search
for
Sort by
Research 301–330 of 1000+
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Metabolic Aspects of Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Insulin resistance and metabolic syndrome in female androgenetic alopecia
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Association of Androgenic Alopecia with Metabolic Syndrome
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- How Does Altered Metabolism Lead to Seizure Control? Partially Filling the Knowledge Gap
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities